MiNK Selected For ARPA-H Program To Advance Room-Temperature Cell Therapy
(RTTNews) - Wednesday, MiNK Therapeutics (INKT) said its agenT-797 iNKT cell therapy platform was selected for an ARPA-H-funded initiative aimed at enabling room-temperature storage and transport of cell therapies.